Abiraterone Acetate Tablet 250mg Tablet About
Spotlight the grandiose efficacy of ARITERON-Abiraterone Acetate Tablet 250mg. Unlock optimum performance in metastatic castration-resistant prostate cancer management with this top-notch and globally approved formulation. Packaged in convenient strips within sturdy boxes, ARITERON adheres to the highest WHO-GMP manufacturing standards. Each film-coated tablet contains high purity Abiraterone Acetate for reliable results and assured safety. Designed for easy oral administration under medical supervision, ARITERON meets global quality standards and competitive pricing, making it a preferred choice for discerning healthcare professionals. Store below 25C, away from light and moisture.
Application & Uses: Precision Focused for Prostate Cancer
ARITERON Abiraterone Acetate Tablet 250mg is specifically indicated for patients with metastatic castration-resistant prostate cancer. Its application surface lies solely within oral administration for adult male patients, ensuring targeted therapy for optimum disease management. While its primary use is for oncologic indications, its formulation and delivery system enable effective absorption and consistent results, making it unsuitable for general or pediatric use. Its clinical effectiveness spotlights its role as a top-choice in advanced prostate cancer care.
Certifications, Transactions & Packaging Insights
Manufactured in a WHO-GMP certified facility, ARITERON guarantees uncompromised quality. The outlay for each order considers competitive global pricing, assuring value at every stage of order completion and exchange. Available in well-sealed box packaging containing strips of film-coated tablets, ARITERON ensures pharmaceutical integrity throughout transit. Stringent expiry and regulatory standards are maintained, and shelf life extends 24 months from manufacture. Payment terms and packaging details can be tailored to meet distributor and healthcare requirements across international markets.
FAQ's of Abiraterone Acetate Tablet 250mg Tablet:
Q: How is ARITERON Abiraterone Acetate Tablet 250mg administered?
A: ARITERON is designed for oral administration and should be taken under the supervision or guidance of a healthcare professional, as per the doctor's prescribed dosage schedule.
Q: What is the primary indication for ARITERON tablets?
A: ARITERON is specifically indicated for the treatment of metastatic castration-resistant prostate cancer and is not intended for use in women or children.
Q: Where is ARITERON manufactured and what certifications does it hold?
A: ARITERON is manufactured in India at a facility fully compliant with WHO-GMP guidelines, ensuring top-notch pharmaceutical standards for global distribution.
Q: What is the shelf life and proper storage condition for ARITERON tablets?
A: Each strip of ARITERON has a shelf life of 24 months from its manufacturing date. Tablets should be stored in a cool, dry place below 25C and kept away from light and moisture.
Q: How can orders be placed for ARITERON, and what packaging details can be expected?
A: Orders for ARITERON can be processed through authorized suppliers or distributors. Each order is completed with secure box packaging containing strips of film-coated tablets and labeled as per international regulatory standards.